Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

Clinical trial NCT00313625 · COMPLETED

Trial details

NCT number: NCT00313625
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2005-09-01
Primary completion: 2007-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.